Suven Pharmaceuticals Hits Record High, Outperforms Sector by 3.86%

Suven Pharmaceuticals, a leading player in the pharmaceuticals and drugs industry, has recently hit an all-time high in its stock price. On October 21, 2024, the company's stock reached a record high of Rs. 1300, surpassing its previous 52-week high. According to MarketsMOJO, a leading financial analysis platform, the current stock call for Suven Pharmaceuticals is 'Hold'. The stock has shown strong performance today, outperforming the sector by 3.86%. It also reached an intraday high of Rs. 1300, showing a 4.84% increase. The stock has been highly volatile today, with an intraday volatility of 12.81%, calculated from the weighted average price. However, Suven Pharma is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its stock price. In the past year, Suven Pharmaceuticals has shown a remarkable performance with a 115.90% increase in its stock price, while the Sensex has only shown a 24.74% increase. This showcases the company's strong growth and potential in the pharmaceutical industry. With its recent all-time high and consistent positive performance, Suven Pharmaceuticals is definitely a company to watch out for in the largecap pharmaceuticals and drugs sector.